Bright Minds Biosciences Inc.
DRUG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827401
No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Bright Minds Biosciences Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 9 | 8 | −1 |
| Shares | 583.6K | 573.7K | −9.93K (−1.7%) |
| Value | $256.7K | $326.3K | +$69.6K (+27.1%) |
New holders (2)
Institutions that held Bright Minds Biosciences Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 16,723 | $9.53K | 0.00% |
| Toronto Dominion Bank | 21 | $0 | 0.00% |
Sold out (3)
Institutions that held Bright Minds Biosciences Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Sawtooth Solutions, LLC | 46,204 | $20.3K |
| Quattro Financial Advisors LLC | 21,150 | $9.31K |
| Aspire Private Capital, LLC | 500 | $220 |